# Tailored Drug Titration Through Artificial Intelligence

> **NCT03397524** · NA · WITHDRAWN · sponsor: **Optima Integrated Health**

## Conditions studied

- Hypertension

## Interventions

- **OTHER:** optima4BP

## Key facts

- **NCT ID:** NCT03397524
- **Lead sponsor:** Optima Integrated Health
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2018-10-01
- **Primary completion:** 2019-12-31
- **Final completion:** 2020-03-31
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** This study was dependent on an IT interoperability component requiring additional development.
- **Last updated:** 2019-09-20

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03397524

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03397524, "Tailored Drug Titration Through Artificial Intelligence". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT03397524. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*